g casino near me

New OGI Camera Detects Fugitive Ammonia and Sulfur Hexafluoride (SF6) Emissions at Industrial and Manufacturing Facilities Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Top trending stories from the past week. News, Sports, and more throughout the week. The week's obituaries, delivered to your inbox.NoneTHOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE Amgeng casino near me 。

Legendary Norfolk folk singer still performing after 40 years

Mead football has put on a defensive masterclass this season, and its efforts have kept it nearly undefeated leading into the Class 3A state semifinals. Its only blemish came during the last week of the regular season against Windsor, which Pomona defeated just last week. Now, the second-seeded Mavericks will face off with No. 3 Pomona for a shot at the state championship. The last time they made an appearance in the title game, in 2021, they lost to Fort Morgan. Now, they have a shot at redemption, but the road won’t be easy. Game details: Saturday, 1 p.m., at Mead High School How Mead can win: Defense, defense, defense. The Mavericks have already shown that they can keep opposing offenses off of the field, and never gave up more than 15 points in a contest before last week’s 34-23 win over No. 7 Pueblo Central. That will be key against a Pomona team that knows how to put up big numbers. How Pomona can win: Keep Mead guessing. The Panthers have proven they can run and throw the ball well, having amassed 2,641 rushing yards and 1,331 passing yards between their two quarterbacks, Tucker Ingersoll and Emmitt Munson. While Munson holds most of the rushing yards with 1,072, he’s far from the only player who can pick up significant yardage. Matchup to watch: Munson vs. Mead’s defense. Last week, the Mavericks held an offensive juggernaut for Pueblo Central, Amari Brown, to just 136 rushing yards. By taking him out of the equation, the Mavericks cruised to victory. They’ll need to do the same for Munson, whether he’s in the pocket or not. To date, Mead has picked up 30.5 sacks and 772 tackles. View a list of Prep sports and high school teams we cover.

The Egyptian real estate market in 2024 saw significant shifts driven by investor interest in hospitality, tourism, and experiential spaces, alongside the rising appeal of the North Coast, particularly with the launch of the Ras El Hekma project. This growing demand from both Egyptian and international buyers is expected to continue shaping the market into 2025. Savills projects that in 2025, leasing and property management advisory services will continue to be in high demand as clients seek expert guidance to optimize their portfolios. The North Coast, boosted by high-profile developments like Ras El Hekma, is set to remain a key focus, driving ongoing interest in the region. Retail spaces are also poised for strong growth over the next two years, with an increasing consumer preference for experiential and lifestyle-oriented environments. Developers will prioritize creating dynamic, engaging spaces that cater to evolving consumer behaviors, shifting the focus from transactional retail to immersive, memorable experiences. Savills Egypt is looking ahead to the next year with a focus on overcoming emerging challenges and leveraging its expertise to drive sustainable growth, forge meaningful partnerships, and support Egypt’s evolving real estate landscape. One of Savills’ major 2024 success stories was its transformation of Majarrah, a flagship mixed-use development by Bonyan for Investment and Development. By focusing on tenant repositioning, marketing innovation, and operational improvements, Savills helped increase occupancy from 54% to 92%, boost foot traffic by 35%, and achieve up to 100% sales growth for tenants. The firm also facilitated record sales of EGP 17bn for Qatari Diar Real Estate Investment Company. Savills’ Building and Project Consultancy team played a crucial role in creating new offices for multinational companies like Bayer, Chevron, Informa, and Organon. Chevron’s Manoji Thomas praised Savills for adhering to budget and schedule. Additionally, Savills achieved a 98.4% occupancy rate and more than 48,000 daily visitors at the new extension of Arkan Plaza, setting a record for commercial projects in West Cairo. Beyond commercial successes, Savills Egypt contributed to national initiatives, including repurposing underutilized land with the World Bank-led consortium and the Sheikh Zayed City Council to support Vision 2030. The firm also provided key advice to the Administrative Capital for Urban Development (ACUD) on large-scale urban projects, collaborating with Dar El Handassa. Catesby Langer-Paget, Head of Savills Egypt, emphasized the firm’s significant role in shaping Egypt’s real estate future in 2024. Langer-Paget said, “Despite the macroeconomic challenges, Savills Egypt continued to deliver value-driven solutions through phased development and cost management. We embraced technology and optimized operations to navigate market complexities.” In 2024, Savills also became a thought leader, hosting the “Savills Retail Connect” event and leading a national workshop with the World Bank, sharing insights from the Sheikh Zayed Pilot Project to guide other municipalities. Looking toward 2025, Savills Egypt plans to focus on emerging sectors like hospitality and logistics, leveraging global expertise and local market insights to drive the evolution of Egypt’s real estate sector. “Savills Egypt has transformed into a partner of progress,” said Langer-Paget, underscoring the firm’s commitment to innovation, value creation, and growth in the years ahead.Rob Cooper, who has worked for the trust since 2015, has taken over from Ann Marr OBE. Mr Cooper has held a number of roles at MWL, including assistant director of operations for medicine, director, and managing director. He has worked in health and social care for many years, and completed his nursing degree at Liverpool University in 1997. READ > Butterfly sculpture recognises hospital's commitment to tissue donation He then worked in A&E, vascular surgery, and intensive care as a nurse, before joining MWL. Mr Cooper said: "Today is a very proud moment for me. "MWL is a fantastic organisation, with a longstanding history of outstanding care, and a trusted reputation in our local communities. "I am truly honoured to be chief executive here. "I’ve been part of MWL for nine years now and over that time I have had the absolute pleasure of working alongside so many amazingly talented staff. "Every part of the NHS is under significant pressure at the moment and the areas of Merseyside and West Lancashire are no exception. "My focus will be on making sure that we continue to look after our patients and our staff to the highest standards against this challenging backdrop. "I’d also like to thank my predecessor, Ann Marr OBE, for her tireless commitment to our patients and staff over her 22 years at the trust. "Ann transformed Whiston and St Helens hospitals into the world-class facilities they are today, leading the former St Helens and Knowsley Trust to receive its outstanding CQC rating." Whiston Hospital (Image: Stock) Richard Fraser, chairman of MWL, said: "Rob’s unwavering focus on quality, patient care and staff experience has always shone through and I am sure with his leadership the trust will continue to be known as one of the leading organisations in the NHS." Mersey and West Lancashire Teaching Hospitals serves a population of more than 600,000 people, with a combined workforce of around 9,000 staff. The trust provides acute and specialist hospital care, intermediate care, and primary care at Whiston, Southport, Ormskirk, St Helens and Newton hospitals, with a wide range of community-based services delivered across the region.

Irish ‘dark horse’ I’m a Celeb star backed to win by former contestantsLululemon stock rises on profit beat as company boosts full-year outlook - Yahoo Finance

Derek Hess, 28, of Penn Laird, attributes his success in finance to his experiences. Hess, named to the Daily News-Record’s 10 Under 40 list by the newspaper’s editorial board, said he has lived in the Shenandoah Valley since he was two years of age. He graduated from James Madison University in 2018 with a major in finance and a minor in economics. Hess then took his first job at PBMares, LLP in Fredericksburg in their Wealth Management division. However, his wife accepted a job in the Valley, so he transitioned to their Harrisonburg branch. Hess said he “always liked the Harrisonburg area.” He enjoys working in the city and appreciates the ability to be a short distance from nature. Hess then decided to work at Hess Financial in 2022 as a a Certified Financial PlannerTM (CFP®). According to Hess, his father started the company in 2011. Hess Financial’s fundamental values are centered on authenticity, relationships and education, according to Hess Financial’s website. Hess said he did not start his career in financial planning because of his father or because he intended to work with him. “I felt the field of financial planning was a good mix of using technical knowledge and working with people,” said Hess. “My father and I agreed that it was important for me to find my way as I started my career, and eventually, our professional paths crossed again organically.” Hess has enjoyed managing his own money and staying organized with it. However, he also wanted to make sure he could have a job interacting with and helping people, said Hess. According to Hess, these skills and attributes make him an excellent fit for financial planning. “It just seemed like it was the right blend of the technical skills and the people-facing career that I wanted,” said Hess. Hess said he enjoys teaching people, coaching them on managing money, and having a better relationship with money. Hess said that growing up in the area and being a part of the professional community today has made being named to the 10 Under 40 list incredibly special to him. “I’m doing the best that I can to show others in my network that even if we’re young and they’re still getting started, there’s a lot that we can do,” said Hess. Hess said that finding opportunities outside of work to contribute has helped him in his career. He encourages others to adopt those behaviors to succeed throughout their careers and become more well-rounded community members. Hess participates with the Young Professionals Association, an organization created by local young professionals in the Harrisonburg area. YPA’s mission is to “connect and engage young professionals by providing social networking, professional development, and volunteer opportunities,” according to YPA’s website. He is also involved at Big Brothers Big Sisters and Massanutten Regional Library. Hess said he has learned a lot from other professionals and mentors, which has helped him grow professionally. Hess, in return, hopes to inspire that same support to those in the community.Robert Kennedy , a business owner, said political parties are promising to build hundreds of thousands of houses but he remained unconvinced about how this could be done. “What I can’t figure out is how they’re going to build them. We know they can finance the houses. Who’s going to build them?” The panel was asked if it had heard anything in the campaign so far that sounded like a feasible solution on this topic. Ken Harper , a former railway executive from the UK, said he was canvassed by Sinn Féin and was given their Home of Your Own housing policy document during that. He felt there was a willingness in their policies to address certain issues that needed to be looked at before building could start, such as making sure the sites were serviced. “I suppose that was a step change in recognising that it’s not just a question of promising to build houses, but actually getting the ducks in a row before work can actually commence. I get the sense that Sinn Féin, the Social Democrats and Labour are willing to embrace something a bit different...whereas with the big two parties it’s really just promising more of the same.” Rebecca Saunders, a primary schoolteacher, recently bought her first home. She said that in Dublin, “all you can see is cranes on the skyline. Stuff is getting built everywhere but what is getting built are hotels and build to rent developments”. She believes the Government’s Help To Buy scheme is “not providing housing in any meaningful way”. Aisling O’Reilly , a 29-year-old tech worker, said she had a “baffling” conversation with Fine Gael Minister for Public Expenditure Paschal Donohoe when she was canvassed by him during the week. She said she asked him about the Help To Buy scheme, telling him it could not help her buy anything in the area around her as it does not extend to homes that are not newly built. “His response to it was ‘sure we couldn’t extend it to the second hand homes because that would push up the price’...I just thought it was a really interesting one.” Jo Cahalan , from Abbeyleix, Co Laois, said she has not been impressed with anything that she has heard. “They are just giving away money now. I’m kind of calling it the political version of Black Friday.” Jo felt that “we don’t have a real alternative. We will simply have a mismatch of all different parties, amounting to the same thing.” She said the number of election promises being made “makes me very nervous”. Gretta Fitzgerald , an advocacy adviser with Concern Worldwide, said she believes the “more left-leaning parties do seem to have a bit more ambition around really tackling some of the issues, such as housing” rather than “doing the same thing over and over again and expecting different results”. Seán Ryan , who lives in rural Co Limerick, said there are “two main government parties (who) are going to get the same vote that they got the last time. The combined opposition, if everyone were organised in three or four parties, then there’d be an alternative. But if 20-25 per cent of the population are going to vote for their local Independent, most of whom are gene pool from one of the traditional parties anyway...” Rebecca Saunders said in relation to Sinn Féin: “They’re not going to be an alternative. They won’t get in. And if they do I think there would be concerns about how they run their party.” Catherine Bergin , a public service worker living in Dundalk, said “I wouldn’t be a supporter of either Fianna Fáil or Fine Gael, but I certainly wouldn’t want to see Sinn Féin in.” She said there may be anxiety among the public about a possible shock to the public finances, which would mean people may not want to “rock the boat”. Tommy Cole , who lives in Tralee, Co Kerry, said that in terms of the parties who are seeking change, “there needs to be the numbers. And most of these parties don’t have the numbers.” However he said that if people did not vote for change then the future would look much the same. Robert Kennedy felt that Mary Lou McDonald came across as “a touch nervous” in the Katie Hannon leaders’ debate. Rebecca Saunders was unimpressed with Simon Harris, and said he was “the worst kind of insincere”. Catherine Bergin felt Fianna Fáil leader Micheál Martin was “an honourable person in comparison to a lot of the more recent leaders” and she felt he was “assertive” in the debate. Tommy Cole was impressed with the performance of People Before Profit leader Richard Boyd Barrett in the debate. Jo Cahalan said she felt Ivana Bacik came across “really well and genuine”. Jennifer Bray is a Political Correspondent with The Irish Times

Syra Health to Present at NobleCon20Federal funding for the nation’s largest abortion provider could be on the chopping block under the direction of Elon Musk and Vivek Ramaswamy and the newly created Department of Government Efficiency (DOGE). In a joint op-ed in the Wall Street Journal published on Wednesday, Musk and Ramaswamy laid out their plans to cut federal overspending and to return power to the “people we elect [to] run the government” rather than unelected bureaucrats. Part of this plan involves slashing millions in funding awarded to “progressive groups like Planned Parenthood,” they wrote. “Skeptics question how much federal spending DOGE can tame through executive action alone,” they wrote “They point to the 1974 Impoundment Control Act, which stops the president from ceasing expenditures authorized by Congress. Mr. Trump has previously suggested this statute is unconstitutional, and we believe the current Supreme Court would likely side with him on this question.” “But even without relying on that view, DOGE will help end federal overspending by taking aim at the $500 billion plus in annual federal expenditures that are unauthorized by Congress or being used in ways that Congress never intended, from $535 million a year to the Corporation for Public Broadcasting and $1.5 billion for grants to international organizations to nearly $300 million to progressive groups like Planned Parenthood,” they continued. President and CEO of Planned Parenthood Federation of America Alexis McGill Johnson responded to the op-ed in a press release on Thursday calling the men “ unqualified fanboys and agents of chaos.” “We’ve been here before — we are not new to shutdown and ‘defund’ fights. We fended off a number of these attacks during Trump’s first term — and Planned Parenthood health centers are still there serving millions of patients across the nation,” she said in part. The op-ed was published the same day 82-year-old Catholic President Joe Biden awarded t he Presidential Medal of Freedom to former Planned Parenthood President Cecile Richards, who oversaw an estimated nearly 4 million abortions while heading the organization between 2006 and 2018. President-elect Donald Trump announced his selection of Musk and Ramaswamy to lead DOGE on November 12, noting that “Republican politicians have dreamed about the objectives of ‘DOGE’ for a very long time.” “Together, these two wonderful Americans will pave the way for my Administration to dismantle Government Bureaucracy, slash excess regulations, cut wasteful expenditures, and restructure Federal Agencies – Essential to the ‘Save America’ Movement,” Trump said. Planned Parenthood’s 2023 annual report reveals that t axpayer funding in the form of government grants, contracts, and Medicaid reimbursements hit $699.3 million, and made up 34 percent of Planned Parenthood’s overall revenue. Planned Parenthood’s taxpayer funding has increased by 43 percent since 2010, according to an analysis by the pro-life Charlotte Lozier Institute. The institute noted that Planned Parenthood’s taxpayer funding is reported by its affiliates, whose information lags behind the national office and covers fiscal years ending in 2022. Planned Parenthood also reported $997.5 million from private contributions, up 44 percent from the previous report. In total, the abortion giant reported nearly $2.1 billion in income and more than $2.5 billion in net assets. The same report shows that Planned Parenthood peformed 392,716 abortions in 2021-2022, a 5-percent increase from the previous year and a 20-percent increase over its past ten reports, according to the institute. Total services were down 17 percent. “In 2021-22, abortions made up 97.1 percent of Planned Parenthood’s pregnancy resolution services, while prenatal services, miscarriage care, and adoption referrals accounted for only 1.6 percent (6,316), 0.9 percent (3,604), and 0.4 percent (1,721), respectively,” according to the institute’s analysis. At the same time, American Life League’s STOPP International 2023 Report on Planned Parenthood CEO Compensation shows , using the latest available data, that the total compensation paid to all Planned Parenthood affiliate CEOs increased from $13.3 million in 2015 to $16.8 million in 2020 — a 26.3-percent increase. The average compensation for a Planned Parenthood CEO rose from $237,999 in 2015 to $317,564 in 2020 — a 33.4-percent increase in five years, according to the report. Katherine Hamilton is a political reporter for Breitbart News. You can follow her on X @thekat_hamilton .

NoneJournalist Pham Chi Dung marks 5 years in prison in Vietnam

How to Make Preserved Flowers Using a Freeze DryerLogility Supply Chain Solutions: Fiscal Q2 Earnings SnapshotLineage, Inc. (LINE) To Go Ex-Dividend on December 31stVictoria’s Secret & Co. Reports Third Quarter 2024 Results

“Tried To Channel Carlos Alcaraz...”: Jessica Pegula Reveals Experiment Which Failed Against Emma Navarro at Garden Cup 2024None